These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
408 related articles for article (PubMed ID: 15535850)
1. Ratios of involved nodes in early breast cancer. Vinh-Hung V; Verschraegen C; Promish DI; Cserni G; Van de Steene J; Tai P; Vlastos G; Voordeckers M; Storme G; Royce M Breast Cancer Res; 2004; 6(6):R680-8. PubMed ID: 15535850 [TBL] [Abstract][Full Text] [Related]
2. Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer. Hatoum HA; Jamali FR; El-Saghir NS; Musallam KM; Seoud M; Dimassi H; Abbas J; Khalife M; Boulos FI; Tawil AN; Geara FB; Salem Z; Shamseddine AA; Al-Feghali K; Shamseddine AI Ann Surg Oncol; 2009 Dec; 16(12):3388-95. PubMed ID: 19655200 [TBL] [Abstract][Full Text] [Related]
3. Functional form of the effect of the numbers of axillary nodes on survival in early breast cancer. Vinh-Hung V; Burzykowski T; Cserni G; Voordeckers M; Van De Steene J; Storme G Int J Oncol; 2003 Mar; 22(3):697-704. PubMed ID: 12579326 [TBL] [Abstract][Full Text] [Related]
4. The lymph node ratio as prognostic factor in node-positive breast cancer. Voordeckers M; Vinh-Hung V; Van de Steene J; Lamote J; Storme G Radiother Oncol; 2004 Mar; 70(3):225-30. PubMed ID: 15064006 [TBL] [Abstract][Full Text] [Related]
5. Association between extent of axillary lymph node dissection and patient, tumor, surgeon, and hospital factors in patients with early breast cancer. Petrik DW; McCready DR; Sawka CA; Goel V J Surg Oncol; 2003 Feb; 82(2):84-90. PubMed ID: 12561062 [TBL] [Abstract][Full Text] [Related]
6. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer. Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207 [TBL] [Abstract][Full Text] [Related]
7. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients]. Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207 [TBL] [Abstract][Full Text] [Related]
8. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection. Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151 [TBL] [Abstract][Full Text] [Related]
9. Lymph node ratio as an alternative to pN staging in node-positive breast cancer. Vinh-Hung V; Verkooijen HM; Fioretta G; Neyroud-Caspar I; Rapiti E; Vlastos G; Deglise C; Usel M; Lutz JM; Bouchardy C J Clin Oncol; 2009 Mar; 27(7):1062-8. PubMed ID: 19164210 [TBL] [Abstract][Full Text] [Related]
10. Effect of axillary lymphadenectomy on breast carcinoma survival. Joslyn SA; Konety BR Breast Cancer Res Treat; 2005 May; 91(1):11-8. PubMed ID: 15868427 [TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes. Truong PT; Berthelet E; Lee J; Kader HA; Olivotto IA Cancer; 2005 May; 103(10):2006-14. PubMed ID: 15812825 [TBL] [Abstract][Full Text] [Related]
12. Micrometastatic node-positive breast cancer: long-term outcomes and identification of high-risk subsets in a large population-based series. Truong PT; Lesperance M; Li KH; MacFarlane R; Speers CH; Chia S Ann Surg Oncol; 2010 Aug; 17(8):2138-46. PubMed ID: 20151215 [TBL] [Abstract][Full Text] [Related]
13. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy. Wright JL; Lin DW; Porter MP Cancer; 2008 Jun; 112(11):2401-8. PubMed ID: 18383515 [TBL] [Abstract][Full Text] [Related]
14. A high number of tumor free axillary lymph nodes from patients with lymph node negative breast carcinoma is associated with poor outcome. Camp RL; Rimm EB; Rimm DL Cancer; 2000 Jan; 88(1):108-13. PubMed ID: 10618612 [TBL] [Abstract][Full Text] [Related]
15. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients? Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642 [TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node biopsy alone has no adverse impact on the survival of patients with breast cancer. Takei H; Suemasu K; Kurosumi M; Horii Y; Ninomiya J; Yoshida M; Hagiwara Y; Inoue K; Tabei T Breast J; 2006; 12(5 Suppl 2):S157-64. PubMed ID: 16958996 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix. Macdonald OK; Chen J; Dodson M; Lee CM; Gaffney DK Am J Clin Oncol; 2009 Aug; 32(4):411-6. PubMed ID: 19451800 [TBL] [Abstract][Full Text] [Related]
18. Does the number of lymph nodes examined in patients with lymph node-negative breast carcinoma have prognostic significance? Salama JK; Heimann R; Lin F; Mehta N; Chmura SJ; Singh R; Kao J Cancer; 2005 Feb; 103(4):664-71. PubMed ID: 15641038 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of the number of positive lymph nodes in women with T1-2N1 breast cancer treated with mastectomy: should patients with 1, 2, and 3 positive lymph nodes be grouped together? Dai Kubicky C; Mongoue-Tchokote S Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1200-5. PubMed ID: 23265570 [TBL] [Abstract][Full Text] [Related]
20. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients. Langer I; Guller U; Hsu-Schmitz SF; Ladewig A; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M Eur J Surg Oncol; 2009 Aug; 35(8):805-13. PubMed ID: 19046846 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]